🇺🇸

Index Intelligence

· daily

S&P 500 Energy Sector SEC Filings — April 20, 2026

Across the four filings in the USA S&P 500 Energy intelligence stream, neutral sentiment prevails with average materiality of 4.25/10, reflecting routine operational, governance, and holdings disclosures rather than major financial shifts. No significant period-over-period comparisons available, but Neogen's completion of operational qualifications for Petrifilm SKUs signals manufacturing progress amid validation efforts, potentially boosting capacity YoY. IIOT-OXYS expanded Series D Convertible Preferred Stock authorization to 500 shares (from unspecified prior, with 210 outstanding at $1,200 stated value), enhancing capital flexibility via board authority for up to 10M preferred shares without shareholder vote. BRT Apartments Corp. demonstrates robust governance with 100% compliance to stock ownership guidelines (CEO 4x salary, directors 3x retainer) and high meeting attendance (≥75% for board/committees), though 64% AGM turnout. Friedenthal Financial's 13F reveals a stable $199.5M portfolio (244 positions, 100% sole discretionary), heavily tilted to ETFs (top: iShares Core S&P Total U.S. at $21.9M/11%). Absent insider trading patterns, guidance changes, or capital allocation shifts, the sector shows stability with no portfolio-level growth/margin trends; implications include low near-term volatility but opportunities in Neogen's investor tours for operational insights.

1 high priority 3 medium 4 total filings
· daily

Dow Jones 30 Stocks SEC Filings — April 20, 2026

Across 50 SEC filings from the USA Dow Jones 30 intelligence stream (April 20, 2026), institutional 13F-HR disclosures dominate (over 70%), revealing overwhelming conviction in mega-cap tech with Apple, Nvidia, Alphabet, and Microsoft comprising top holdings in 25+ portfolios totaling billions, signaling sustained bullish momentum in Big Tech despite no QoQ changes. Banking sector shows resilient Q1 2026 earnings with ServisFirst Bancshares NI +31.2% YoY (EPS +31%) and NIM +61 bps YoY, Investar Holding NI +113% QoQ post-acquisition, though marred by rising NPAs (ServisFirst 1.00% vs 0.40% YoY). M&A catalysts advance with Calavo Growers HSR clearance for Mission Produce merger (expected Q ending July 31, 2026) and Piermont Valley SPAC deal valuing Tigerless Health at $280M (H2 2026 close). Steel recovery mixed at Cleveland-Cliffs with rev +6% YoY but $229M net loss; energy trusts falter (San Juan Basin no April distribution amid costs > rev by $5M). High materiality risks from bankruptcies/delisting (QVC Group 10/10, Charles & Colvard 10/10) highlight consumer distress, while biotech/fintech fundraising (Enveric $5-13.9M, Faraday $45M notes) adds dilutive pressures. Portfolio-level trends: NIM expansion in 2/3 banks (avg +50 bps), but credit deterioration (NPAs up); tech holdings stable across RIAs averaging 30-50% allocation.

14 high priority 36 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — April 20, 2026

Across 50 filings dominated by regional bank Q1 2026 earnings and proxy statements, key themes include resilient loan and deposit growth (avg +5-8% annualized QoQ across 6 banks) offsetting NIM compression (-5-10 bps QoQ in 4/6 cases) and mixed profitability (3/6 banks hit record NI). Consumer Discretionary touches like Cleveland-Cliffs (steel/auto) show revenue acceleration (+6% YoY, +14% QoQ) with improved EBITDA but weather-impacted losses, while Aptiv and American Axle highlight strong governance ahead of AGMs. Institutional 13F-HR filings (12 instances) reveal persistent mega-cap tech bias (AAPL, AMZN, GOOG top holdings in 10/12), signaling defensive positioning. M&A activity (e.g., Columbia/Northfield merger, Brookfield Oaktree acquisition) and debt amendments (e.g., Fortress extension to 2028) indicate active capital markets, but derivative losses (Infinity $65M) and covenant waivers (FMC leverage) flag vulnerabilities. Forward-looking stability in Cleveland-Cliffs FY shipments (16.5-17M tons) and multiple AGMs in May-June 2026 build a catalyst-rich calendar. Overall, mixed sentiment (12/50) underscores banking strength amid macro pressures, with actionable alpha in outperforming lenders and governance plays.

13 high priority 37 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — April 20, 2026

The 50 filings, despite the Healthcare stream focus, predominantly feature regional banks' Q1 2026 earnings with YoY net income growth averaging +35% across 7 reporters (e.g., Wintrust +2% QoQ record, Zions +38% EPS YoY, Columbia +47% YoY), offset by QoQ softness in NIM (e.g., Zions -4bps, BOK -8bps) and deposits in some, alongside improving credit quality (charge-offs down in 5/7). Institutional 13Fs (15 filings) reveal persistent overweight in tech mega-caps (Apple, MSFT, NVDA, AMZN top in 12/15, Eli Lilly prominent in Tower View $8.9M and Lilly Endowment $84.5B stake) and ETFs, signaling defensive equity/bond tilts amid volatility. Biotech highlights include positive capital raises (Enveric $5M upfront +$8.9M potential, Dare $100K Reg A closing) contrasting DAQO's -35% FY2025 revenue decline. Proxy/AGM cluster (20+ filings) peaks May-June 2026 with director elections and auditor ratifications, mostly neutral. Mixed sentiment dominates (12/50), with banking resilience and tech conviction as key themes implying sector rotation opportunities into financials post-Q1 strength.

13 high priority 37 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — April 17, 2026

The 20 filings reveal a bifurcated S&P 500 Technology landscape: robust institutional conviction in mega-cap tech leaders (Broadcom, Apple, Nvidia topping multiple 13Fs with $3.7B+ positions) contrasts sharply with distress in micro/small-cap tech/biotech adjacents (MBIO delisting risk, Madison Tech zero revenues/losses +6.4% YoY, Acquisition Corp cash to $85). Key period trends include Tencent Music's strong consolidated revenue +15.9% YoY to RMB32.9B and profit +59.7% YoY, offset by VIE gross profit -55.5% YoY; Chemung Financial Q1 NI +53.3% YoY (tech holdings heavy); mixed SPAC swings to losses. Critical developments: MAIR IPO at $27/share (82M shares, trading Apr 16), Cumulus $600M debt cut via bankruptcy approval, C2 Blockchain insider cancels 245M shares, TI strong AGM votes (board 100% elected). Capital allocation leans conservative (Chemung $0.34 div, Evommune no divs planned); no major insider buys/sells beyond C2 reduction. Portfolio implications: overweight large-cap semis/AI (13Fs aggregate billions in AVGO/NVDA/AAPL), avoid microcaps, monitor IPOs/restructures for alpha.

7 high priority 13 medium 20 total filings
· daily

Nasdaq 100 Stocks SEC Filings — April 17, 2026

Across 20 NASDAQ-100 related filings from April 17, 2026, key themes include robust growth in entertainment/streaming (Netflix +16.2% YoY revenue, +82.8% net income; Tencent Music +15.9% revenue, +59.7% profit) contrasting with distress in smaller tech/biotech firms (Madison Technologies net loss +6.4% YoY to $2.98M, Mustang Bio Nasdaq delisting notice). Period-over-period trends show 3/5 operating companies with double-digit revenue growth (avg +16%) but mixed profitability (2/5 with widening losses), while 5/20 filings highlight capital raises/IPOs (Madison Air $27/share IPO) and restructurings (Cumulus $600M debt elimination). 13F filings (4/20) reveal concentrated exposure to mega-caps like Broadcom ($3.7B top holding), Apple, Alphabet. Proxy battles and board changes signal governance focus (TXI strong approvals, Faraday 3 resignations/3 appointments). Material events like bankruptcies, delistings, and upcoming AGMs create volatility, with positive sentiment in 4/20 (20%) vs negative in 4/20 (20%). Portfolio implications: Favor large-cap streamers over micro-caps amid proxy season catalysts.

11 high priority 9 medium 20 total filings
· daily

S&P 500 Financials Sector SEC Filings — April 17, 2026

Across 50 SEC filings from the USA S&P 500 Financials stream (April 17, 2026), S&P 500 banks like Regions, Truist, Ally, Fifth Third, FNB, and State Street showed resilient YoY performance with average EPS growth of ~35% (e.g., Ally +90%, Truist +25%) and revenue up ~12% YoY, driven by fee income and deposit growth, though NIM compressed ~3-5 bps QoQ amid merger costs and loan shifts. Margin pressures persisted in non-bank filings like Zhihu (-24% YoY revenue), DouYu (-10.6% YoY), and ZTO (-10.5% gross profit YoY), contrasting growth in Atour (+35% YoY) and Tencent Music (+15.9% YoY). Distressed signals emerged in QVC/QVC Group Chapter 11 bankruptcies, while M&A/SPACs (Viking/NorthStar $300M valuation, Tri Pointe merger) and capital raises (InvenTrust $250M notes, PMGC $40M equity) highlighted restructuring. Proxy filings dominated neutrally for June AGMs, with limited insider data but buyback programs (News Corp $1B). Capital allocation leaned toward buybacks/repurchases over dividends, with improving credit quality (e.g., Regions NPL 0.71%). Portfolio trend: 6/6 banks beat YoY EPS, signaling sector strength despite headwinds; watch NIM and mergers for Q2 catalysts.

30 high priority 20 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — April 17, 2026

Across the 50 filings in the USA S&P 500 Consumer Staples intelligence stream (with diverse cross-sector exposure including select staples like Hain Celestial), proxy season dominates with 20+ DEF 14A/DEFA14A filings signaling governance focus ahead of clustered May-June 2026 annual meetings. Period-over-period trends reveal robust revenue growth in 6/12 financial reporters (avg +37% YoY: Polestar +50.3%, Casella +18%, Yelp record $1.46B, Dream Homes x2), but mixed profitability (5/12 saw net income/losses worsen: Casella -41.9%, Polestar net loss +15%, Stellar -10.6%). Capital raises/M&A active (e.g., PMGC $40M facility, Liftoff IPO, Brookfield $1B notes), with positive sentiment in 12% of filings tied to growth/strategic pivots. No widespread insider trading reported, but executive retention (Hain $5M bonuses) and board changes (Rockwell addition, Faraday resignations) indicate transition themes. Forward-looking catalysts include 15+ meetings and Diamond Hill merger close April 22; staples exposure limited but Hain's retention amid strategic review flags M&A potential. Overall, revenue resilience amid cost pressures suggests selective buying opportunities in outperformers.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — April 17, 2026

Across 50 SEC filings from S&P 500 Industrials and related sectors on April 17, 2026, overarching themes include heavy institutional 13F disclosures overweight in tech stocks (Apple, MSFT, NVDA) and ETFs signaling persistent risk-on appetite, mixed Q1 bank earnings with robust NII growth (e.g., FFIN +13.5% YoY, Fifth Third +34% YoY) offsetting merger charges and expense surges (+83% QoQ at Fifth Third), and Industrials strength via Otis' 5% service sales growth and $1.5B shareholder returns. Auditor changes at LanzaTech and Global Tech amid material weaknesses and receivership highlight governance risks, while M&A/debt positives like Centessa's $38/share Lilly buyout (+CVR) and Emergent Bio's 200bps interest savings shine. Period-over-period trends show net income volatility (FFIN +16.6% YoY, Stellar -10.6% YoY), improving NIMs in banks (FFIN 3.86%, Fifth Third +17bps), but worsening losses in biotechs (Day One -12.3% YoY). Portfolio-level patterns: 20+ 13Fs aggregate $100B+ AUM with tech/ETF concentration implying sector rotation potential; proxy-heavy filings signal AGM catalyst cluster May-June. Critical implications: Opportunistic M&A in stressed names, monitor bank deposit flight and auditor fixes for industrials-adjacent plays.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — April 17, 2026

The six filings for the USA S&P 500 Energy stream highlight a dominant theme of leadership disruption at Southern Copper Corp (SCCO), with the unexpected CEO passing on April 13, 2026, prompting an immediate interim CEO appointment effective April 16 across three filings (8-K, DEF 14A, DEFA14A), ensuring continuity amid an upcoming May 29, 2026 AGM. Hooker Furnishings Corp (HOOK) dominates operational insights, reporting FY2026 net sales down 12.4% YoY to $278.1M (Hooker Branded -2.9%, Domestic Upholstery -2.7%, All Other -61.5%), yet gross margins expanded +180bps to 26.4% while operating losses widened to -6.0% from -3.0% and net loss to -4.6% from -1.9%. Executive compensation at HOOK ties FY2027 incentives (30% revenue, 70% operating income) and PSUs (EPS CAGR threshold 5%/target 10%/max 25%, TSR 25th-75th percentile) through 2029, signaling long-term alignment. Halbert Hargrove's 13F reveals a $2.07B ETF-heavy portfolio (S&P 500 ETF $328M top holding) with hedges via puts on Apple/Airbnb/Home Depot. No broad sector revenue growth trends emerge (1/6 filings with YoY data shows contraction), but margin resilience contrasts sales weakness; implications include SCCO volatility risks and HOOK supply chain vulnerabilities from Vietnam/Asia. Portfolio-level patterns show proxy/leadership focus (4/6 filings) over financials, urging monitoring of SCCO succession and HOOK Q4 impacts from fewer weeks/supplier delays.

4 high priority 2 medium 6 total filings
· daily

Dow Jones 30 Stocks SEC Filings — April 17, 2026

Across 50 SEC filings from the USA Dow Jones 30 intelligence stream (April 17, 2026 period), overarching themes include robust M&A/SPAC activity in space/tech/defense (e.g., Viking-NorthStar $300M deal, Soluna $16.5M acquisition, PMGC $40M facility), mixed bank earnings post-mergers with strong NII growth offsetting charges (FFIN +13.5% YoY NII to $134.79M, Fifth Third +34% YoY NII to $1.939B), and acute distress in consumer retail (QVC Group Chapter 11 with $2.9B debt acceleration, equity cancellation). Period-over-period trends show revenue growth in 7/18 quantifiable filings averaging +19% YoY (Atour +35.1%, Autoliv +6.8% organic), but declines in 4 cases (-10.6% DouYu, -15.9% Atour leased hotels); margins mixed with bank NIM expansions (Fifth Third +17bps to 3.30%) vs. Autoliv OI -6.7% to 8.6%. Critical developments: QVC bankruptcy signals retail weakness, Theriva positive Phase 2b data as biotech catalyst, multiple auditor changes/resignations (GTII, Volato) flag small-cap instability. Portfolio-level patterns: 6/50 positive capital allocation (Autoliv $300-500M buybacks, Permianville $0.01/unit dist), 5 compliance risks (Avalon, Global Interactive Nasdaq notices), forward catalysts cluster in late April (Theriva AACR 4/20, Calavo vote 4/28). Implications: Bullish for SPAC/growth plays, cautious on consumer/merger integrations, monitor small-cap delistings.

28 high priority 22 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — April 17, 2026

Across 50 SEC filings dated April 17, 2026, primarily from financials, energy/infra, and select consumer discretionary names, Q1 2026 bank earnings dominate with average YoY net income growth of ~17% (e.g., FNB +18%, First Financial +16.6%, Truist +19%) but QoQ declines averaging 20-80% due to merger charges and NIM compression (-3 to -5 bps across Regions, Truist, FNB). M&A activity surges with accretive deals like Uinta's $20M refinery acquisition (EBITDA 3x growth via Shell offtake), Fifth Third's $12.7B Comerica integration (NII +34% YoY), and TransDigm's Stellant buy ($1B financing). IPO/SPAC momentum evident in QuasarEdge's $115M upsized offering and Liftoff Mobile's 21% YoY customer growth S-1. Proxy season launches with 20+ annual meetings May-June, mostly neutral/positive (Energy Fuels, Firefly highlight growth). Consumer discretionary outliers like Atour Lifestyle show 35% YoY revenue surge (retail/manachised hotels), while risks emerge in debt defaults (Borealis $16M acceleration) and exec churn (American Axle). Portfolio implication: Favor resilient banks with buybacks (Truist $1.1B), monitor NIM trends; alpha in infra M&A and IPOs amid mixed sector sentiment (28% positive, 24% mixed, 44% neutral).

25 high priority 25 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — April 17, 2026

Across 50 filings in the USA S&P 500 Healthcare stream (with broader financial context from first 28 new filings), healthcare activity remains sparse, focusing on biotech governance (Tyra Biosciences, Dare Bioscience, Emmaus Life Sciences director changes) and funding (Revolution Medicines $500M convertible notes, CEL-SCI S-1 offering), signaling pipeline investment amid neutral sentiment. Abbott Laboratories resolved infant formula litigation overhang via preliminary settlement approval. Dominating filings are regional banks' Q1 2026 earnings (FFIN +16.6% YoY NI, Regions +15% adj EPS YoY, Truist +25% EPS YoY, Ally +90% adj EPS YoY, Chemung +53.3% YoY NI), averaging 37% YoY net income/EPS growth but with QoQ NII declines (-0.8% to -2.8%) and NIM compression (-3 to -5 bps in 3/5) due to deposit shifts. Capital allocation leans shareholder-friendly (Truist $1.1B buyback, News Corp $1B program, Chemung $0.34 dividend), with proxy season ramping (10+ AGMs May-June). No insider trading patterns detected; sentiment mixed (positive in appointments/debt, neutral in proxies/13Fs). Portfolio implication: Opportunistic healthcare catalysts amid resilient bank earnings, watch NIM trends and biotech AGMs for conviction signals.

17 high priority 33 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — April 16, 2026

Across 17 filings in the S&P 500 Technology stream, proxy statements dominate for tech leaders Arista Networks and Salesforce, signaling stable governance with experienced boards focused on AI, cloud, and cybersecurity ahead of May AGMs, while 13Fs from four institutions (Klaas, Paladin, Rockland, First Community) reaffirm $500M+ collective exposure to mega-tech (NVDA $11.8M total, AAPL $73.8M+, MSFT $9.9M+, GOOG $132M+, AMAT $9.8M) as of Q1 2026 end, indicating sustained institutional conviction amid no disclosed QoQ changes. Non-tech context filings highlight routine capital activities (e.g., dividend adjustments, share authorizations) with neutral sentiment overall, but mixed signals like abrdn VFL's junk muni policy shift to 100% exposure and Texas Bancshares' loan deteriorations underscore credit risks outside core tech. No explicit YoY/QoQ financial trends in proxies/13Fs, but forward-looking AGMs (May-June 2026) and special meetings build a catalyst calendar; capital allocation leans conservative with maintained dividends and no buybacks noted. Sector implications favor big tech stability via 13F holdings, with Arista/Salesforce governance votes as near-term events, though dilution risks from share increases (Altimmune +400M shares) warrant caution. Portfolio-level pattern: 4/17 filings (tech proxies + 13Fs) drive bullish tech overweight, contrasting neutral/mixed non-core.

6 high priority 11 medium 17 total filings
· daily

Nasdaq 100 Stocks SEC Filings — April 16, 2026

Across 21 filings from NASDAQ-100 related entities, dominant themes include robust Q1 2026 earnings beats from blue-chips like PepsiCo (revenue +8.5% YoY to $19.4B, OP +24%, EPS +27%) and Netflix (revenue +16% YoY to $12.3B, OP margin +60bps to 32.3%), affirming FY guidance amid volume headwinds and content spend pressures. Proxy statements (Meta, Netflix, Immunocore, Texas Community) highlight governance focus with upcoming AGMs in May-June 2026, director elections, and shareholder proposals on AI, pay, ESG. Capital allocation shines with PepsiCo's 54th consecutive dividend hike (+4%) and Community Bancorp's $0.25/share quarterly payout, while financings bolster EV/battery plays (Faraday Future +$2M to $12M investment, International Battery $2.8M insider-led). Mixed sentiments prevail in 7/21 filings, driven by volume declines (Pepsi organic -3%), rising debt (Pepsi short-term x2), and riskier policies (abrdn junk bonds to 100% assets). Portfolio-level trends show consumer giants outpacing with 12-24% OP growth vs. modest cash flows, signaling reinvestment over returns; no broad insider selling patterns, but director retirements neutral. Implications: Bullish for staples/streaming stability, watch governance votes and May catalysts for volatility.

9 high priority 12 medium 21 total filings
· daily

S&P 500 Financials Sector SEC Filings — April 16, 2026

Across 50 SEC filings from S&P 500 Financials and related entities (banks, insurers, asset managers, services), sentiment is predominantly mixed (24/50), with positive outliers in revenue growth (e.g., avg +15-30% YoY in TSMC +31.6%, Bilibili +13.1%, KeyCorp NII +11%) but persistent net losses widening/narrowing unevenly (e.g., Capstone loss +728%, Ionetix +32%). Banks like First Financial Bancorp and Cathay General Bancorp highlight M&A (Westfield/BankFinancial acquisitions) and strong 2025 performance, while asset managers (Brookfield, abrdn) pursue debt raises and policy shifts for yield. Capital allocation trends favor shareholder returns (KeyCorp $389M buybacks, News Corp $1B program, PepsiCo 4% dividend hike), with 12+ companies announcing dividends/buybacks/splits. Proxy season intensifies with 15+ AGMs May-June 2026 (e.g., Cohen & Co June 3, Glaukos May 28), signaling governance catalysts. Forward-looking data flags divestitures (CareDx Q3 2026 close), earnings (Corebridge May 4/5), and guidance (PepsiCo FY2026 organic 2-4%). Portfolio-level: Revenue resilient (+ avg 10% YoY in 20 reporters) but op margins volatile (-150bps avg compression in 8/10 mixed cos), implying selective opportunities in banks amid sector rotation.

30 high priority 20 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — April 16, 2026

Across 50 filings dated April 16, 2026, proxy statements dominate (e.g., DEF 14A/DEFA14A for Excelerate Energy, Stellus entities, Glaukos, Korro Bio, Colgate-Palmolive, Clearway), signaling peak proxy season with neutral sentiment and upcoming AGMs in May-June 2026. Q1 2026 earnings reveal resilient profits amid revenue softness: PepsiCo revenue +8.5% YoY/organic +2.6% but volumes -3%; Travelers NI +333% YoY on lower cat losses; Marsh & McLennan revenue +8% but GAAP income -12% on litigation charge. Consumer Staples highlights include PepsiCo affirming FY2026 organic revenue 2-4%/EPS 4-6% growth with 4% dividend hike (54th consecutive), while CCEP and Colgate prep neutral AGMs. Capital allocation trends strong with $2.2B shareholder returns at Travelers, $755M buybacks at Marsh; margin compression evident in industrials (Lakeland -820bps YoY). Portfolio-level patterns show 7/12 earnings reporters with YoY profit growth >20% despite mixed volumes/pricing, bullish advisor upgrades (Stellus/Ridgepost $43B AUM), but covenant waivers (Katapult 10th) flag credit risks. Implications: Favor staples dividend payers like PEP/CL amid volatility; monitor May earnings catalysts for guidance updates.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — April 16, 2026

The 50 filings for USA S&P 500 Industrials stream reveal a skew toward financials/banks (e.g., US Bancorp, BNY, Bank First) showing robust YoY revenue/NII growth averaging ~15-20% (US Bancorp +4.7%, BNY +13%, Bank First NII +45.8%) driven by acquisitions and partnerships, though QoQ declines (e.g., US Bancorp -1%, BNY Investment/Wealth -3%) signal seasonal softness and margin pressures (Bank First NIM -1.2% QoQ). Proxy statements dominate (20+ filings) heralding AGM season May-June 2026 with director elections and say-on-pay votes, mostly neutral. Operating companies mixed: revenue growth in Ionetix +67.7% YoY but wider losses, SurgePays -6% YoY with equity deficit -$15.4M; narrowing losses in Catalyst Crew -95% op ex drop, Brand Engagement +176% rev. Capital allocation favors shareholders via dividend hikes (Bank First +22.2% YoY, First Interstate $311.9M returns =103% NI) and buybacks. Debt refinancings/raises positive (Herbalife $800M, Lincoln Educational to $125M). 13Fs show big tech concentration (NVIDIA/MSFT/AAPL top across AEGON, Sander, etc.). Portfolio implication: overweight banks with NII momentum, monitor May earnings for guidance amid acquisition integrations.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — April 16, 2026

Hooker Furnishings (the sole filing in this S&P 500 Energy stream snapshot) reported fiscal 2026 results marked by revenue declines of 12.4% YoY to $278.1M and 20.5% YoY in Q4 to $67.0M, driven by shorter quarter, lower hospitality shipments, and weather disruptions, yet demonstrated robust cost discipline with $26.3M in fixed cost cuts, $11.9M SG&A reduction, and 180 bps gross margin expansion. Full-year operating loss of $16.5M was largely due to $15.6M non-cash impairments, partially offset by positive Q4 operating income of $0.6M. The company completed divestitures of Pulaski Furniture and Samuel Lawrence Furniture, authorized a $5M share repurchase program, and adjusted its annual dividend to $0.46 per share, signaling focus on core operations and shareholder returns. Liquidity strengthened post-year-end to $12M cash and $64.1M available borrowing capacity as of April 15, 2026, with no credit facility balance. Mixed sentiment reflects revenue weakness balanced by efficiency gains, positioning Hooker as a potential turnaround amid sector scrutiny. Key implication: Cost savings of $17.5M tied to continuing operations could drive profitability recovery if sales stabilize.

1 medium 1 total filings
· daily

Dow Jones 30 Stocks SEC Filings — April 16, 2026

Across the 50 SEC filings from the USA Dow Jones 30 intelligence stream (primarily financials, insurers, and related blue-chips, with some small-caps), Q1 2026 earnings dominate, revealing strong YoY net income growth averaging +100% in key financials (Travelers +333%, BNY +42% EPS, US Bancorp +13.8%, BancFirst +12.3%, Bank First +9.9%) driven by lower catastrophe losses, NII expansion (Bank First +45.8% YoY), and fee growth, though QoQ dips (-4.9% NI US Bancorp), premium declines (Travelers -2% NWP), and NIM compression (Bank First -1.2% QoQ) signal moderating momentum. Capital allocation remains shareholder-friendly with dividend increases (Travelers +14% to $1.25, Bank First +22.2% YoY to $0.55) and buybacks ($2.223B Travelers Q1, $1.8B 10-Q). Small-caps show distress patterns: revenue drops (Hooker -20.5% Q4, Vipshop -2.3% FY), net losses, dilution risks (RenovoRx 16M shares), auditor changes (LanzaTech), and filing delays (CETI, AMC). Biotech highlights include MeiraGTx positive 3-yr clinical data (17-pt XQ improvement) and J&J asset buy ($25M upfront). Over 15 proxy filings cluster AGMs in May-Jun 2026 as near-term catalysts, with neutral sentiment but positive exec comp approvals. Portfolio-level: Financials outperform (ROE 19.7% Travelers), but watch margin trends and small-cap liquidity; actionable buy dips in strong capital returners.

26 high priority 24 medium 50 total filings